A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine

Clinical trial NCT05652543 · COMPLETED

Trial details

NCT number: NCT05652543
Sponsor: Sinocelltech Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Pandemic

Start date: 2023-01-05
Primary completion: 2024-01-15
Enrollment: 518

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.